Renishaw Lowered to “Hold” at Nplus1 Brewin (RSW)
Renishaw (LON:RSW) was downgraded by stock analysts at Nplus1 Brewin to a “hold” rating in a report issued on Monday, Stock Ratings News reports. They currently have a GBX 1,675 ($27.10) price objective on the stock. Nplus1 Brewin’s price target would indicate a potential upside of 3.53% from the stock’s previous close.
Renishaw (LON:RSW) traded down 1.10% during mid-day trading on Monday, hitting GBX 1617.9451. 62,907 shares of the company’s stock traded hands. Renishaw has a 52-week low of GBX 1444.00 and a 52-week high of GBX 2128.50. The stock’s 50-day moving average is GBX 1768. and its 200-day moving average is GBX 1688.. The company’s market cap is £1.178 billion.
Other equities research analysts have also recently issued reports about the stock. Analysts at N+1 Singer reiterated a “hold” rating on shares of Renishaw in a research note to investors on Monday, October 21st. They now have a GBX 1,675 ($27.10) price target on the stock. Separately, analysts at Goldman Sachs Group Inc. downgraded shares of Renishaw to a “neutral” rating in a research note to investors on Tuesday, October 15th. They now have a GBX 2,100 ($33.98) price target on the stock, up previously from GBX 1,800 ($29.12). Finally, analysts at Numis Securities Ltd reiterated a “hold” rating on shares of Renishaw in a research note to investors on Tuesday, October 15th. They now have a GBX 1,700 ($27.50) price target on the stock. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has assigned a buy rating to the company. Renishaw presently has a consensus rating of “Hold” and a consensus price target of GBX 1,739.01 ($28.13).
Renishaw plc is engaged in the design, manufacture and sale of advanced precision metrology and inspection equipment together with products for the healthcare sector, including Raman spectroscopy systems, dental systems, molecular diagnostic equipment and neurosurgical products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.